An understudied type of liver cell may drive scarring in liver disease and could be a promising target for new treatments, suggests a new study by Weill Cornell Medicine investigators.
Back to News
Weill Cornell MedicineOffice of External Affairs
1300 York AvenueBox 314
New York, NY 10065
Phone: (646) 962-9476